Title
Attention Deficit/Hyperactivity Disorder And Methylphenidate: A Review Of Height/Weight, Cardiovascular, And Somatic Complaint Side Effects
Abstract
Three classes (height/weight, cardiovascular, and somatic complaints) of treatment emergent symptoms (side effects) associated with methylphenidate (MPH) therapy for children with attention deficit/hyperactivity disorder (ADHD) are reviewed. The more easily quantifiable side effects (e.g., blood pressure [BP], heart rate [HR], height/weight) are mostly transient, dose-dependent, easily rectified with dosage adjustments, and considered minor from a clinical perspective considering the breadth and level of improvement in behavior and cognitive functioning observed in most children. Previously reported somatic complaints associated with psychostimulant therapy may reflect symptoms occurring prior to initiation of treatment and require additional study. © 2002 Elsevier Science Ltd. All rights reserved.
Publication Date
11-1-2002
Publication Title
Clinical Psychology Review
Volume
22
Issue
8
Number of Pages
1107-1131
Document Type
Review
Personal Identifier
scopus
DOI Link
https://doi.org/10.1016/S0272-7358(02)00129-0
Copyright Status
Unknown
Socpus ID
0036837114 (Scopus)
Source API URL
https://api.elsevier.com/content/abstract/scopus_id/0036837114
STARS Citation
Rapport, Mark D. and Moffitt, Catherine, "Attention Deficit/Hyperactivity Disorder And Methylphenidate: A Review Of Height/Weight, Cardiovascular, And Somatic Complaint Side Effects" (2002). Scopus Export 2000s. 2426.
https://stars.library.ucf.edu/scopus2000/2426